Galectin-10 Is Released in the Nasal Lavage Fluid of Patients with Aspirin-Sensitive Respiratory Disease

Table 1

Clinical characteristics of the study group.

	HC	ATA	ASRD
Subjects (𝑛)	15	10	15
AGE (years)	23 (21–34)	39 (14–62)	47 (28–74)
Gender M : F	8 : 7	4 : 6	2 : 13
Atopic (%)	0	30	47
Blood Eosinophiis (×10^3/mm^3)	0.17±0.16	0.52±0.26	0.50±0.42^∗
IgE (IU/mL)	76.8±65.4	229.5±438.2	267.8±320.7
Lisil-aspirin challenge (+)	0	0	15
Methacholine PC20 (mg/mL)	>32	3.0±2	2.5±1
Mean basal FEV (% predicted)	107±6	103±22	97±12

HC: Healthy Controls.
ATA: Aspirin-Tolerant Asthmatics.
ASRD: Aspirin-Sensitive Respiratory Disease patients.
FEV: Forced-expiratory-volume.
^∗𝑃>0.05 ASRD versus ATA.